Bristol-Myers Squibb SA
Bristol-Myers Squibb SA is a Originators company based in Steinhausen (Zug) recorded by Swissmedic as the authorisation holder for 24 human medicines. That places it 78 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Steinhausen |
| Canton | Zug |
| Authorisation holder | Yes |
| Medicines | 24 |
| Founded | 2002 |
| Employees | 201-1000 |
| Parent group | Bristol Myers Squibb |
| Activity | Not available |
| Website | bms.com |
Medicines authorised in Switzerland
Bristol-Myers Squibb SA is recorded by Swissmedic as the authorisation holder for 24 human medicines. The table shows 24 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
24 of 24 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Abecma Infusionsdispersion | 67575 | A | L01XL07 | 2021-08-20 |
| Abraxane 100 mg | 63182 | A | L01CD01 | 2014-08-26 |
| Baraclude 0.05 mg/mL | 57436 | A | J05AF10 | 2006-08-10 |
| Baraclude 0.5 mg | 57435 | A | J05AF10 | 2006-08-10 |
| Breyanzi | 67469 | A | L01XL08 | 2022-03-28 |
| Camzyos 2.5 mg | 68477 | B | C01EB24 | 2023-04-25 |
| Eliquis 2.5 mg | 61549 | B | B01AF02 | 2011-08-26 |
| Empliciti 300 mg | 65920 | A | L01XC23 | 2016-06-06 |
| Imnovid 1 mg | 61249 | A | L04AX06 | 2014-06-02 |
| Lenalidomid BMS 2 | 68490 | A | L04AX04 | 2021-06-14 |
| Nulojix 250 mg | 61521 | A | L04AA28 | 2011-12-15 |
| Onureg 200 mg | 67802 | A | L01BC07 | 2021-09-16 |
| Opdivo 40 mg/4 ml | 65660 | A | L01FF01 | 2015-11-30 |
| Opdivo subkutan 600 mg/5 ml | 70192 | A | L01FF01 | 2026-01-28 |
| Opdualag (80 mg Relatlimab / 240 mg Nivolumab pro 20 ml) | 68609 | A | L01FY02 | 2022-12-23 |
| Orencia | 62141 | B | L04AA24 | 2012-02-27 |
| Orencia 125 mg/1 ml | 65833 | B | L04AA24 | 2016-03-15 |
| Orencia 250 mg | 57769 | A | L04AA24 | 2007-08-03 |
| Reblozyl 25 mg | 69592 | A | B03XA06 | 2026-05-21 |
| REVLIMID 5 mg | 57712 | A | L04AX04 | 2007-08-29 |
| Sprycel 20 mg | 57658 | A | L01EA02 | 2007-02-02 |
| Vidaza 100 mg | 57380 | A | L01BC07 | 2006-02-24 |
| YERVOY 50 mg/10 ml | 61798 | A | L01FX04 | 2011-10-14 |
| Zeposia 0.23 mg | 67046 | B | L04AE02 | 2020-08-11 |
Frequently asked questions
How many medicines does Bristol-Myers Squibb SA have authorised in Switzerland?
Bristol-Myers Squibb SA is recorded by Swissmedic as the authorisation holder for 24 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Bristol-Myers Squibb SA based?
The Swiss location recorded for Bristol-Myers Squibb SA is Steinhausen, Zug.
Is Bristol-Myers Squibb SA a Swissmedic authorisation holder?
Yes. Bristol-Myers Squibb SA appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.